Palisade Bio Inc (NASDAQ: PALI) Receives A Worldwide Exclusive License Concerning A Technology Developed By The University Of California Scientist

Palisade Bio Inc (NASDAQ: PALI) recently announced to receive an exclusive license from the University of California for a technology developed by Dr. Michael Heller in the laboratory at UC San Diego. The license is related to a proprietary technology that detects enzymatic protease activity in human clinical subjects. Together […]